Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 16 , ISSUE 3 ( May-June, 2024 ) > List of Articles

Original Article

Injection Tranexamic Acid in Preventing Postpartum Hemorrhage Following Vaginal Delivery: A One-year Hospital-based Randomized Placebo-controlled Trial

Kshama Hinchigeri, Kamal P Patil, Ankita Patil, Mrityunjay C Metgud

Keywords : Adverse effects, Blood loss, Postpartum hemorrhage, Tranexamic acid, Uterotonics

Citation Information : Hinchigeri K, Patil KP, Patil A, Metgud MC. Injection Tranexamic Acid in Preventing Postpartum Hemorrhage Following Vaginal Delivery: A One-year Hospital-based Randomized Placebo-controlled Trial. J South Asian Feder Obs Gynae 2024; 16 (3):239-242.

DOI: 10.5005/jp-journals-10006-2413

License: CC BY-NC 4.0

Published Online: 29-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Introduction: Tranexamic acid (TXA) injections, known for their antifibrinolytic properties, are gaining wider acceptance as a treatment for postpartum hemorrhage (PPH) on a global scale. Aims and objectives: The purpose of this study was to evaluate the effectiveness of TXA and its potential side effects in preventing PPH following vaginal birth. Materials and methods: This randomized controlled trial, conducted in a multispecialty hospital in Belagavi, India, involved 210 term patients over 1 year from January to December 2019. Subjects were randomly assigned into two cohorts using computer-based randomization. Each cohort received 10 prophylactic units of oxytocin. One group received 1 gm of intravenous TXA, while the other received 10 mL of normal saline intravenously within 2 minutes after delivery. Blood loss was measured using calibrated drapes, and mean changes in hemoglobin (Hb) and packed cell volume (PCV) were assessed from pre-delivery to postnatal day 2. Data assessment was carried out using the statistical program R i386 3.6.3. Results: Patients in the research had an average age of 23.43 years with a standard deviation (SD) of 3.26 years. The occurrence of PPH was observed in 5 individuals (4.85%) in the TXA group and 12 individuals (11.21%) in the placebo group (p = 0.0912). Furthermore, the mean blood loss was significantly lesser in the TXA group, measuring 250.10 mL with an SD of 133.54 mL, compared to 334.2 mL with an SD of 141.78 mL in the placebo group (p < 0.0001). Conclusion: Tranexamic acid can serve as a supplementary treatment alongside uterotonics during the third stage of labor, given its demonstrated clinical effectiveness and safety in preventing PPH.

PDF Share
  1. Nigussie J, Girma B, Molla A, et al. Magnitude of postpartum hemorrhage and its associated factors in Ethiopia: A systematic review and meta-analysis. Reprod Health 2022;19(1):63. DOI: 10.1186/s12978-022-01360-7.
  2. Bazirete O, Nzayirambaho M, Umubyeyi A, et al. Risk factors for postpartum haemorrhage in the Northern Province of Rwanda: A case control study. PLoS One 2022;17(2):e0263731. DOI: 10.1371/journal.pone.0263731.
  3. McLintock C. Prevention and treatment of postpartum hemorrhage: Focus on hematological aspects of management. Hematology Am Soc Hematol Educ Program 2020;2020(1):542–546. DOI: 10.1182/hematology.2020000139.
  4. Muñoz M, Stensballe J, Ducloy-Bouthors AS, et al. Patient blood management in obstetrics: Prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus 2019;17(2):112–136. DOI: 10.2450/2019.0245-18.
  5. Schmidt P, Skelly CL, Raines DA. Placental Abruption. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. PMID: 29493960.
  6. Salati JA, Leathersich SJ, Williams MJ, et al. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev 2019;4(4):CD001808. DOI: 10.1002/14651858.CD001808.pub3.
  7. Mielke RT, Obermeyer S. The use of tranexamic acid to prevent postpartum hemorrhage. J Midwifery Womens Health 2020;65(3):410. DOI: 10.1111/jmwh.13101.
  8. Albaz Z. Role of prophylactic tranexamic acid in reducing blood loss during elective cesarean delivery. J Fam Med 2020;7(8):1227. Available from:
  9. Shahbazi Sighaldeh S, Nazari A, Maasoumi R, et al. Prevalence, related factors and maternal outcomes of primary postpartum haemorrhage in governmental hospitals in Kabul-Afghanistan. BMC Pregnancy Childbirth 2020;20(1):1–9. DOI: 10.1186/s12884-020-03123-3.
  10. Dahiya K, Shalu. Efficacy and safety of tranexamic acid in the prevention of postpartum haemorrhage after vaginal delivery. Int J Clin Obstet Gynaecol 2021;5(3):377–381. DOI: 10.33545/gynae.2021.v5.i3f.950.
  11. Nambiar MJ, Somu K. The effect of tranexamic acid on blood loss after vaginal delivery. Indian Journal of Obstetrics and Gynecology Research 2020;5(4):559–562. DOI: 10.18231/2394-2754.2018.0125.
  12. Al-Garhy ET, Mohamed AH, Barakat IA. Effect of tranexamic acid on blood loss in elective cesarean delivery. Egypt J Hosp Med 2019;74(6):1314. DOI: 10.21608/ejhm.2019.26689.
  13. Almutairi WM. Incidences of atonic postpartum hemorrhage and related risk factors at a Tertiary Hospital in Saudi Arabia. Nurs Rep 2020;10(2):164. DOI: 10.3390/nursrep10020020.
  14. Igboke FN, Obi VO, Dimejesi BI, et al. Tranexamic acid for reducing blood loss following vaginal delivery: A double-blind randomized controlled trial. BMC Pregnancy Childbirth 2022;22(1):1–8. DOI:
  15. Saccone G, della Corte L, Ardino B, et al. Prophylactic use of tranexamic acid after vaginal delivery reduces the risk of primary postpartum hemorrhage. J Matern Feotal Neonatal Med 2020;33(19):3368–3376. DOI: 10.1080/14767058.2019.1571576.
  16. Xia Y, Griffiths BB, Xue Q. Tranexamic acid for postpartum hemorrhage prevention in vaginal delivery: A meta-analysis. Medicine (Baltimore) 2020;99(3):e18792. DOI: 10.1097/MD.0000000000018792.
  17. Franchini M, Mengoli C, Cruciani M, et al. Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: An updated systematic review and meta-analysis. Blood transfusion 2018;16(4):329. DOI: 10.2450/2018.0026-18.
  18. Naeiji Z, Delshadiyan N, Saleh S, et al. Prophylactic use of tranexamic acid for decreasing the blood loss in elective cesarean section: A placebo-controlled randomized clinical trial. J Gynecol Obstet Hum Reprod 2021;50(1):101973. DOI: 10.1016/j.jogoh.2020.10197.
  19. Oseni RO, Zakari M, Adamou N, et al. Effectiveness of preoperative tranexamic acid in reducing blood loss during caesarean section at Aminu Kano Teaching Hospital, Kano: A randomized controlled trial. Pan Afr Med J 2021;39:34. DOI: 10.11604/pamj.2021.39.34.21938.
  20. Shakur-Still H, Roberts I, Fawole B, et al. Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): A single-centre, randomised, double-blind, placebo-controlled trial. Wellcome Open Res 2018;3:100. DOI: 10.12688/wellcomeopenres.
  21. Sentilhes L, Daniel V, Deneux-Tharaux C. TRAAP2-TRAnexamic acid for preventing postpartum hemorrhage after cesarean delivery: A multicenter randomized, doubleblind, placebo-controlled trial-a study protocol. BMC Pregnancy Childbirth 2020;20:63. DOI:
  22. Ifunanya NJ, Chukwu IC, Nobert OC, et al. Tranexamic acid versus placebo for prevention of primary postpartum haemorrhage among high risk women undergoing caesarean section in abakaliki: A randomized controlled trial. Open J Obstet Gynecol 2019;9(6): 914–922. DOI: 10.4236/ojog.2019.96089.
  23. Tran NT, Bar-Zeev S, Schulte-Hillen C, et al. Tranexamic acid for postpartum hemorrhage treatment in low-resource settings: A rapid scoping review. Int J Environ Res Public Health 2022;19(12):7385. DOI:
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.